1Parsonnet J,Fdedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma [ J ]. N Engl J Meal,1991,325(16) :11127 -11131.
2Huang ZG, Duan GC, Fan QT, et al. Mutation of eytotoxin-associated gene A affects expressions of anfioxidant proteins of Helicobacter pylori[ J ]. World J Gastroenterol, 2009,15 ( 5 ) : 599 - 606.
3Akopyants NS, Clifton SW, Kersulyte D, et al. Analyses of the cag pathogenicity island of Helicobacter pylori[ J]. Mol Microbiol, 1998,28 ( 1 ) : 37 - 53.
4Hsu PI, Hwang IR, Cittelly D, et al. Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island[ J]. Am J Gastroenterrol,2002,97 (9) :2231 - 2238.
8[1]Maxwell SRJ. Prospects for the use of antioxidant therapies[J].Drugs, 1995,49:345 - 361.
9[2]Sherman L, Dafni N, Lieman - Hurwitz J, et al. Nucleotide sequence and expression of human chromosome 21 - encoded superoxide dismutase Mrna[J]. ProNatl Acad Sci, U S A, 1983, 80(18):5465 - 5469.
10[3]RA Hallewell, FR Masiarz, RC Najarien. human Cu/Zn superoxide dismutase cDNA.: isolation of clones synthesising high level of active or inactive enzyme from an expression library [ J ]. Nucleic Acids Res, 1985, 13:2017 -2034.
